Novo Nordisk is cutting the out-of-pocket prices of its popular weight-loss drug Wegovy and diabetes drug Ozempic for some consumers.
Current customers who pay for the drugs out of pocket — without the help of health insurance — will now be charged $349 per month, down from $499, the Danish drugmaker said Monday.
Novo Nordisk also announced that it will charge $199 per month for new patients who pay for the drugs out of pocket, with the offer covering two months of the treatments. After that, the cost of the drugs will rise to $349 per month. The introductory $199 offer will be available through March 31, 2026, it said.
The new pricing for people who pay out of pocket for the two popular drugs comes amid a push from the Trump administration to lower their prices. In a deal announced earlier this month, the administration said people who rely on Medicare, Medicaid and the planned "TrumpRx" pharmaceutical website will get lower pricing for Novo Nordisk's GLP-1 drugs, as well as Eli Lilly's Zepbound.
At the time, administration officials said the drugs would cost an average of $245 to $350, a more accessible price point given they can retail for more than $1,000 per month.
Dave Moore, executive vice president of U.S. operations of Novo Nordisk, told CBS News in a statement that the company's new offer is intended to expand access to medicines for patients living with chronic diseases.
"Novo Nordisk is making it easier and more affordable for patients to access real FDA-approved treatments," he said.
Customers can get prescriptions at the new prices at wegovy.com or ozempic.com, at NovoCare Pharmacy or through other select providers such as Costco.
When the employed are pushed into homelessness
President Trump's pardon of crypto billionaire sparks concerns over his use of pardons
latest_posts
- 1
European Travel Objections for 2024 - 2This widow influencer is using jokes to cope after her husband's death. It's OK if people don't get it.
- 3Ukraine Now Using Drone Boats To Attack Russian Riverine Targets
- 4Trump administration launches new immigration crackdowns in New Orleans and Minneapolis. Here are all the cities it has targeted so far.
- 5Big majority in Germany call Berlin's efforts on gas prices too weak
- Tzrifin base exhibition reveals Hamas and Hezbollah arms, showing structure behind attacks
- What to know about MIT professor Nuno Loureiro and the investigation into his shooting
- Faulty glucose monitors linked to 7 deaths and more than 700 injuries, FDA warns
- The Most Compelling Innovation Developments Somewhat recently
- Shooting of MIT professor Nuno Loureiro has police searching for a suspect
- Polar bears are rewiring their own genetics to survive a warming climate
- Am I a Summer, or is this a scam? What I learned from color analysis.
- The moon up close: How the Artemis 2 astronauts are photographing their historic lunar flyby
- Artemis 2 astronauts see Earth in the rear-view mirror | Space photo of the day for April 3, 2026
